{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "in-respect-of", "type": "clause", "offset": [7, 20]}], "size": 14, "snippet": "means, in respect of:", "samples": [{"hash": "iTjn9h48mVr", "uri": "https://www.hyflux.com/wp-content/uploads/2019/02/Section-2101-OS_Hydrochem-with-annexes.pdf", "label": "www.hyflux.com", "score": 10.4496917725, "published": false}, {"hash": "iEesunXS37o", "uri": "http://hyflux.com/wp-content/uploads/2019/03/20190326-Addendum-to-Hydrochem-Explanatory-Statement.pdf", "label": "hyflux.com", "score": 9.6146478653, "published": false}, {"hash": "aOZQOOsTZ5w", "uri": "http://hyflux.com/wp-content/uploads/2019/03/20190326-Addendum-to-HMM-Explanatory-Statement.pdf", "label": "hyflux.com", "score": 9.6146478653, "published": false}], "hash": "08656ebc11f50a0650d284549cef83ca", "id": 1}, {"snippet_links": [{"key": "the-transaction-agreement", "type": "clause", "offset": [53, 78]}], "size": 14, "snippet": "means \u201cScheme Consideration\u201d under and as defined in the Transaction Agreement.", "samples": [{"hash": "jfUqB7bzpDY", "uri": "/contracts/jfUqB7bzpDY#scheme-consideration", "label": "364 Day Bridge Credit Agreement", "score": 31.3408622742, "published": true}, {"hash": "9uPJ816SPYS", "uri": "/contracts/9uPJ816SPYS#scheme-consideration", "label": "Term Loan Credit Agreement", "score": 30.6765937805, "published": true}, {"hash": "3irMptjLrSL", "uri": "/contracts/3irMptjLrSL#scheme-consideration", "label": "364 Day Bridge Credit Agreement", "score": 30.6765937805, "published": true}], "hash": "265f2bdfc4a038bc353d13ec2a12d7df", "id": 2}, {"snippet_links": [{"key": "cash-consideration", "type": "clause", "offset": [25, 43]}, {"key": "share-consideration", "type": "clause", "offset": [52, 71]}, {"key": "the-value", "type": "clause", "offset": [73, 82]}, {"key": "date-of", "type": "clause", "offset": [122, 129]}, {"key": "the-transaction-agreement", "type": "clause", "offset": [130, 155]}], "size": 6, "snippet": "means, collectively, the Cash Consideration and the Share Consideration, the value of which shall be determined as of the date of the Transaction Agreement.", "samples": [{"hash": "fYM5dy47Z0G", "uri": "/contracts/fYM5dy47Z0G#scheme-consideration", "label": "Expenses Reimbursement Agreement (AbbVie Inc.)", "score": 30.4784393311, "published": true}, {"hash": "9vpA1W8aslr", "uri": "/contracts/9vpA1W8aslr#scheme-consideration", "label": "Expense Reimbursement Agreement (Allergan PLC)", "score": 30.4784393311, "published": true}, {"hash": "9BtfYGJmk1A", "uri": "/contracts/9BtfYGJmk1A#scheme-consideration", "label": "Expense Reimbursement Agreement", "score": 30.3053283691, "published": true}], "hash": "4f78d56f7f4f9a82a6a9481c4537e8b4", "id": 3}, {"snippet_links": [{"key": "payable-to", "type": "definition", "offset": [24, 34]}, {"key": "scheme-shareholders", "type": "definition", "offset": [35, 54]}, {"key": "at-the-effective-time", "type": "clause", "offset": [58, 79]}, {"key": "in-exchange", "type": "clause", "offset": [80, 91]}, {"key": "transfer-of-the-scheme-shares", "type": "clause", "offset": [100, 129]}, {"key": "in-accordance-with", "type": "definition", "offset": [137, 155]}, {"key": "eligible-persons", "type": "clause", "offset": [188, 204]}, {"key": "the-option", "type": "clause", "offset": [206, 216]}, {"key": "cash-consideration", "type": "clause", "offset": [224, 242]}, {"key": "first-share-consideration", "type": "definition", "offset": [248, 273]}, {"key": "combination-of-both", "type": "clause", "offset": [280, 299]}, {"key": "specified-number", "type": "definition", "offset": [315, 331]}, {"key": "eligible-scheme", "type": "definition", "offset": [345, 360]}, {"key": "in-all-other-cases", "type": "clause", "offset": [382, 400]}, {"key": "other-share-consideration", "type": "definition", "offset": [406, 431]}], "size": 6, "snippet": "means the consideration payable to Scheme Shareholders as at the Effective Time in exchange for the transfer of the Scheme Shares to AQY in accordance with this Scheme, comprising (1) for eligible Persons, the option of the Cash Consideration, the First Share Consideration, or a combination of both, for up to the Specified Number held by each eligible Scheme Shareholder, and (2) in all other cases, the Other Share Consideration;", "samples": [{"hash": "kW49mBlNVL1", "uri": "/contracts/kW49mBlNVL1#scheme-consideration", "label": "Arrangement Agreement (Sagicor Financial Co Ltd.)", "score": 30.9603004456, "published": true}, {"hash": "evbqIUIGcRV", "uri": "https://filecache.investorroom.com/mr5ircnw_sagicor/515/Amendment-to-Circular-and-Scheme.pdf", "label": "Notice", "score": 18.3108711243, "published": false}, {"hash": "evbqIUIGcRV", "uri": "https://www.sagicor.com/-/media/PDFs/SFC/Shareholder-Documents/Amendment-to-Circular-and-Scheme.pdf?la=en&hash=D9947F9A0454CD75C314E5459902CF78F84C6F9A", "label": "Notice", "score": 13.6611909866, "published": false}], "hash": "6b22a44da49f35cb0c692de0e37cbfdd", "id": 4}, {"snippet_links": [{"key": "exchange-ratio-modification-number", "type": "definition", "offset": [43, 77]}, {"key": "allergan-share", "type": "definition", "offset": [125, 139]}, {"key": "in-lieu-of", "type": "clause", "offset": [219, 229]}], "size": 5, "snippet": "means 0.8660 (as it may be adjusted by the Exchange Ratio Modification Number) of an AbbVie Share plus US$120.30 in cash per Allergan Share (as it may be adjusted by the Exchange Ratio Modification Number) and any cash in lieu of fractions.", "samples": [{"hash": "i0uskWnErEr", "uri": "https://www.sec.gov/Archives/edgar/data/1578845/000119312519181327/d771837dex991.htm", "label": "Allergan PLC", "score": 14.4784393311, "published": false}, {"hash": "2TWRqAgiIic", "uri": "https://www.sec.gov/Archives/edgar/data/1551152/000110465919037446/a19-12093_1ex99d1.htm", "label": "AbbVie Inc.", "score": 14.4784393311, "published": false}, {"hash": "icDCG2Vw1DE", "uri": "https://www.allergan.com/-/media/allergan/documents/us/Investors/AbbVie/Europe-Rule-2point5-Announcement-Acquisiton-of-Allergan-pls-by-AbbVie-Inc.pdf", "label": "www.allergan.com", "score": 10.9014377594, "published": false}], "hash": "3f60e06ac7e265424df8f68a242b09ac", "id": 5}, {"snippet_links": [{"key": "in-respect-of", "type": "clause", "offset": [27, 40]}, {"key": "the-scheme", "type": "clause", "offset": [67, 77]}, {"key": "pursuant-to-section", "type": "clause", "offset": [98, 117]}, {"key": "the-transaction-agreement", "type": "clause", "offset": [131, 156]}], "size": 4, "snippet": "means 1.08 of an Aon Share in respect of each WTW Share subject to the Scheme (as may be adjusted pursuant to Section 2.1(d)(v) of the Transaction Agreement).", "samples": [{"hash": "XDvi9gqAD7", "uri": "/contracts/XDvi9gqAD7#scheme-consideration", "label": "Expense Reimbursement Agreement (Aon PLC)", "score": 31.1875419617, "published": true}, {"hash": "5XP8FU3KRGQ", "uri": "/contracts/5XP8FU3KRGQ#scheme-consideration", "label": "Expense Reimbursement Agreement (Willis Towers Watson PLC)", "score": 31.1848049164, "published": true}, {"hash": "jsnT9RajfX0", "uri": "/contracts/jsnT9RajfX0#scheme-consideration", "label": "Expense Reimbursement Agreement", "score": 24.5961666107, "published": true}], "hash": "803c2ed74b390a32b2fc93ce85b1bcc4", "id": 6}, {"snippet_links": [{"key": "payable-to", "type": "definition", "offset": [24, 34]}, {"key": "in-accordance-with", "type": "definition", "offset": [53, 71]}, {"key": "the-scheme", "type": "clause", "offset": [72, 82]}], "size": 4, "snippet": "means the consideration payable to IONA Shareholders in accordance with the Scheme.", "samples": [{"hash": "9PcSUZMfY05", "uri": "/contracts/9PcSUZMfY05#scheme-consideration", "label": "Implementation Agreement (Iona Technologies PLC)", "score": 21.0, "published": true}, {"hash": "6hMd6oMXrBA", "uri": "/contracts/6hMd6oMXrBA#scheme-consideration", "label": "Implementation Agreement (Progress Software Corp /Ma)", "score": 21.0, "published": true}, {"hash": "7lJalq5P963", "uri": "https://investors.progress.com/static-files/946d30a5-21a9-447f-8b26-a8f6b63cda35", "label": "investors.progress.com", "score": 14.6824417114, "published": false}], "hash": "cd3ecd617c03d1cd8b211ec53bc2baaa", "id": 7}, {"snippet_links": [{"key": "in-clause", "type": "clause", "offset": [42, 51]}], "size": 4, "snippet": "shall have the meaning given to that term in Clause 8.1(c)(i)(B);", "samples": [{"hash": "h4r5JnAyF2p", "uri": "/contracts/h4r5JnAyF2p#scheme-consideration", "label": "Transaction Agreement (Covidien PLC)", "score": 23.4544830322, "published": true}, {"hash": "ki4L15J0HZa", "uri": "/contracts/ki4L15J0HZa#scheme-consideration", "label": "Transaction Agreement (Eaton Corp)", "score": 21.3928813934, "published": true}, {"hash": "5FDFyzpyZx1", "uri": "/contracts/5FDFyzpyZx1#scheme-consideration", "label": "Transaction Agreement (Cooper Industries PLC)", "score": 21.3928813934, "published": true}], "hash": "5d8ce8399960e8d445fafbcc97cc573b", "id": 8}, {"snippet_links": [{"key": "relevant-portion", "type": "definition", "offset": [10, 26]}, {"key": "rights-and-interests", "type": "definition", "offset": [34, 54]}, {"key": "term-sheet", "type": "clause", "offset": [62, 72]}, {"key": "new-notes", "type": "definition", "offset": [73, 82]}, {"key": "perpetual-notes", "type": "definition", "offset": [92, 107]}, {"key": "new-shares", "type": "definition", "offset": [116, 126]}, {"key": "the-participating", "type": "clause", "offset": [148, 165]}, {"key": "scheme-creditors", "type": "definition", "offset": [166, 182]}, {"key": "designated-recipients", "type": "clause", "offset": [193, 214]}, {"key": "terms-of-the", "type": "clause", "offset": [257, 269]}, {"key": "the-distribution-agreement", "type": "clause", "offset": [282, 308]}], "size": 3, "snippet": "means the relevant portion of the rights and interests in the Term Sheet New Notes, the New Perpetual Notes and the New Shares to be distributed to the Participating Scheme Creditors (or their Designated Recipients, as applicable) under and pursuant to the terms of the Schemes and the Distribution Agreement.", "samples": [{"hash": "fR7xzI047x8", "uri": "https://www.sec.gov/Archives/edgar/data/1700493/000095010317002615/dp74172_t3e2.htm", "label": "Enrestechnology LLC", "score": 12.2169742584, "published": false}, {"hash": "4cNMouEgU7h", "uri": "https://www.sec.gov/Archives/edgar/data/1700493/000095010317002615/dp74172_t3e1.htm", "label": "Enrestechnology LLC", "score": 12.2169742584, "published": false}, {"hash": "3TpJ9Et7hPe", "uri": "https://www.sec.gov/Archives/edgar/data/1700493/000095010317002615/dp74172_t3e3.htm", "label": "Enrestechnology LLC", "score": 10.2169742584, "published": false}], "hash": "46dbbc265ef870c297780e05cc1b377f", "id": 9}, {"snippet_links": [{"key": "consideration-to-be-paid", "type": "clause", "offset": [10, 34]}, {"key": "option-holders", "type": "clause", "offset": [45, 59]}, {"key": "cancellation-of", "type": "clause", "offset": [68, 83]}, {"key": "in-accordance-with", "type": "definition", "offset": [115, 133]}, {"key": "clause-5", "type": "definition", "offset": [134, 142]}], "size": 3, "snippet": "means the consideration to be paid to Scheme Option Holders for the cancellation of each Scheme Option, calculated in accordance with clause 5.", "samples": [{"hash": "cqLr1a0ooGc", "uri": "/contracts/cqLr1a0ooGc#scheme-consideration", "label": "Implementation Deed (Constellation Brands Inc)", "score": 18.0, "published": true}, {"hash": "iDRmjx9aPC1", "uri": "https://ir.cbrands.com/sec-filings/all-sec-filings/content/0000901309-03-000144/0000901309-03-000144.pdf", "label": "ir.cbrands.com", "score": 9.0616016388, "published": false}, {"hash": "i4xrXHDlGSG", "uri": "https://www.sec.gov/Archives/edgar/data/16918/000104746903005338/a2103123zex-99_1.htm", "label": "Constellation Brands Inc", "score": 5.0, "published": false}], "hash": "fb2cccbdb214727779174f0d409c82c6", "id": 10}], "next_curs": "CmESW2oVc35sYXdpbnNpZGVyY29udHJhY3Rzcj0LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIdc2NoZW1lLWNvbnNpZGVyYXRpb24jMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 152, "snippet": "means, in respect of:", "title": "Scheme Consideration", "id": "scheme-consideration", "examples": ["For clarity, the provisions of this Section 10.1 do not apply to any announcement, document or publication in connection with a Company Alternative Proposal, Company Superior Proposal or a Company Board Change of Recommendation or any amendment to the terms of the Scheme proposed by Parent that would effect an increase in the <strong>Scheme Consideration</strong> whether before or after an Company Board Change of Recommendation.", "Within fourteen (14) days following the Effective Date, in respect of each Company Share subject to the Scheme (excluding Company Shares held by current or former employees of the Company Group that are subject to unvested Company Restricted Stock Awards as of immediately prior to the Effective Time), Parent shall pay, or cause to be paid, in respect of each holder of Company Shares at the Scheme Record Time, the <strong>Scheme Consideration</strong> in accordance with the terms and conditions of the Scheme."], "related": [["share-consideration", "Share Consideration", "Share Consideration"], ["per-share-consideration", "Per Share Consideration", "Per Share Consideration"], ["net-consideration", "Net Consideration", "Net Consideration"], ["base-consideration", "Base Consideration", "Base Consideration"], ["earnout-consideration", "Earnout Consideration", "Earnout Consideration"]], "related_snippets": [], "updated": "2026-01-07T05:17:25+00:00"}, "json": true, "cursor": ""}}